
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
pS2 CRISPR/Cas9 KO Plasmid (h) | sc-402867 | 20 µg | $397.00 |
TFF1, also known as pS2, encodes a secreted trefoil factor that contributes to epithelial barrier integrity and mucosal repair by promoting cell migration and regulating restitution after injury. In human tissues it is prominently expressed in gastric and breast epithelium and is commonly regulated by hormone-responsive transcriptional programs, linking it to differentiation and luminal epithelial phenotypes. pS2 participates in stress and inflammation-adjacent signaling that influences epithelial homeostasis, including interactions with mucins and modulation of growth factor–associated responses. Dysregulated TFF1 expression is frequently used as a molecular readout in studies of gastrointestinal metaplasia and estrogen receptor–positive breast cancer biology, where it can reflect changes in epithelial state and microenvironmental signaling.
pS2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TFF1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TFF1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TFF1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish pS2 protein expression.
This CRISPR knockout system enables efficient generation of TFF1-deficient cell models for investigation of pS2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.